Gene Mack, MBA
Board Member
Gain Therapeutics, Inc. (GANX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gene Mack, MBA
Gene Mack, MBA is recorded as CEO, Board Member and CFO at Gain Therapeutics, Inc. (GANX). Gain Therapeutics, Inc. reported in an 8-K filed January 7, 2025 that Gene Mack, MBA was appointed member of the Company's Board of Directors, effective January 6, 2025. Gain Therapeutics, Inc. reported in an 8-K filed January 7, 2025 that Gene Mack, MBA was appointed President and Chief Executive Officer, effective January 6, 2025. Gain Therapeutics, Inc. reported in an 8-K filed April 8, 2024 that Gene Mack, MBA was appointed Chief Financial Officer, effective April 8, 2024.
“Mr. Mack has also been appointed as a member of the Company's Board of Directors, effective January 6, 2025.”
“Gene Mack, who has served as the Company's Chief Financial Officer since April 2024 and interim Chief Executive Officer since June 2024, has been appointed President and Chief Executive Officer, effective January 6, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-01-06–present
-
Current
2025-01-06–present
-
Current
2024-04-08–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Gain Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Gene Mack CEO, CFO, Board Member
- Matthias Alder CEO, COO, Board Member
- Dr. Khalid Islam Chairman
- Khalid Islam Chairman
- C. Evan Ballantyne CFO
- Gianluca Fuggetta Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.